Get started
Author

Jana Gawron

ORCID: 0009-0006-6409-655X
Observed ORCID: 0009-0006-6409-655X
OpenAlex ID: A5039985754
Murine astrovirus tropism for goblet cells and enterocytes facilitates an IFN-λ response in vivo and in enteroid cultures
2021 · Harshad Ingle, Ebrahim Hassan, et al. · Mucosal Immunology · 44
PDF
Metabolic and Lipidomic Assessment of Kidney Cells Exposed to Nephrotoxic Vancomycin Dosages
2021 · Simon Lagies, Roman Pichler, et al. · International Journal of Molecular Sciences · 16
PDF
AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling
2025 · Alexander Zähringer, Inês Morgado, et al. · Blood Advances · 12
Interferon-λ Receptor Expression: Novel Reporter Mouse Reveals Within- and Cross-Tissue Heterogeneity
2020 · Julian Linden, Daniel Schnepf, et al. · Journal of Interferon & Cytokine Research · 9
Gastrin for the treatment of acute graft-versus-host disease of the stomach
2026 · Jana Gawron, Marie Czech, et al. · Blood · 4
NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway
2026 · Eri Matsuki, Masahiro Miyata, et al. · Haematologica · 1
Donor–recipient microbiome identity in haematopoietic stem cell grafting
2026 · Anna Li, Jana Gawron, et al. · Trends Open
Pegtarazimod limits acute graft-versus-host disease mortality and severity in mice and is tolerated in patients
2026 · Verena Holzmüller, Jana Gawron, et al. · Journal of Clinical Investigation
PDF
NLRP6 regulates ZAP-70-erk signaling in both murine and human T cells and influences acute graft-versus-host disease(GVHD)
2025 · Eri Matsuki, Masahiro Miyata, et al. · Blood
PDF
Gastrin for the treatment of acute graft-versus-host disease of the stomach
2025 · Jana Gawron, Marie Czech, et al. · Blood
Exploring a Novel Anti-Inflammatory Peptide As a Potential Treatment for Acute Graft-Versus-Host Disease (aGVHD)
2024 · Verena Holzmüller, Ulrich Thienel, et al. · Blood
The decrease of HCV-specific neutralizing antibody responses after DAA therapy is associated with weak envelope-specific CD4 T cell immunity
2024 · Jill Werner, Jana Gawron, et al. · Zeitschrift für Gastroenterologie
The decrease of HCV-specific neutralizing antibody responses after DAA therapy is associated with weak envelope-specific CD4 T cell immunity
2023 · Jana Gawron, Jill Werner, et al. · Journal of Hepatology
Works count: 13
Citation count: 86
H-index: 4
I10-index: 3
Year
Topic
Type